Molecular diagnostics laboratory P23 Labs reported on Friday the availability of its new P23 Respiratory ONE test to detect respiratory illnesses that share symptoms with COVID-19 when test results for COVID-19 are negative and the patient is still not healthy.
The company added that the P23 Respiratory ONE can detect the common cold, five different Influenza strains and five Coronavirus strains including COVID-19. The test results are available 48 hours from lab receipt.
According to the company, the P23 Respiratory ONE takes a single COVID-19 sample, whether it is the non-invasive saliva sample or the nasal swab sample. The kits are shipped directly to patients to allow sample collection from the comfort of their own home.
If anyone is presenting COVID-19 symptoms and working with their physician to obtain a COVID-19 order, the patient should also tell their physician that they would like to have a test that identifies what illness they do have if it is not COVID-19, concluded the company.
AstraZeneca wins US FDA approval for Tezspire in chronic rhinosinusitis with nasal polyps
Sichuan Kelun-Biotech presents positive Phase 3 trial results for sac-TMT
SOPHiA DDM Digital Twins launched to simulate patient outcomes and support oncology decisions
Novocure announces presentation of new TTFields research at EANO and ESMO 2025 meetings
Mabwell to present latest 7MW3711 clinical results at 2025 ESMO Congress
Actinium Pharmaceuticals to reveal ATNM-400 data in NSCLC at AACR-NCI-EORTC International Conference
Tempus selected by ARPA-H to provide CRO and testing services for ADAPT cancer programme
Polarean expands Ascend Imaging partnership to boost US market reach